Canonical ingredient
D-Streptamine, O-3-amino-3-deoxy-? -D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3 ,6-trideoxy-?-D-ribo-hexopyranosyl-(1.fwdarw. 4)]-2-deoxy-
TOBRAMYCIN
14 linked products
Official identifiers
Names and synonyms
- D-Streptamine, O-3-amino-3-deoxy-? -D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3 ,6-trideoxy-?-D-ribo-hexopyranosyl-(1.fwdarw. 4)]-2-deoxy- (en)
- Tobramycine (fr)
- O-3-amino-3-déoxy-?-D-glucopyranosyl-(1—>6)-O-[2,6-diamino-2,3,6-tridéoxy-?-D-ribo-hexopyranosyl-(1—>4)]-2-déoxy- D-streptamine (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Equivalent concepts in other registries
These links require an exact shared identifier; names alone are never sufficient.
- tobramycin
GLOBAL · CAS 32986-56-4
Verification source
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
AJ-TOBRAMYCIN
40 · MG · ML
APO-TOBRAMYCIN
0.3 · %
PMS-TOBRAMYCIN 0.3% OPHTHALMIC SOLUTION
3 · MG · ML
SANDOZ TOBRAMYCIN
0.3 · %
SANDOZ TOBRAMYCIN / DEXAMETHASONE
0.3 · % · W/V
SANDOZ TOBRAMYCIN / DEXAMETHASONE
0.3 · % · W/W
TOBI PODHALER
28 · MG
TOBRADEX
0.3 · % · W/V
TOBRADEX
0.3 · % · W/W
TOBRAMYCIN INJECTION, USP
40 · MG · ML
TOBRAMYCIN OPHTHALMIC SOLUTION USP 0.3%
3 · MG · ML
TOBREX
0.3 · % · W/V
TOBREX
0.3 · % · W/W
TOBREXAN
0.3 · % · W/V